Compare SENEB & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SENEB | CMMB |
|---|---|---|
| Founded | 1949 | 2004 |
| Country | United States | Israel |
| Employees | N/A | 12 |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 20.5M |
| IPO Year | 1998 | 2023 |
| Metric | SENEB | CMMB |
|---|---|---|
| Price | $188.22 | $2.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 316.0 | ★ 117.4K |
| Earning Date | 06-11-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 101.67 |
| EPS | ★ 2.85 | 0.04 |
| Revenue | ★ $1,314,765,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $66.04 | $70.00 |
| Revenue Growth | ★ 4.16 | N/A |
| 52 Week Low | $104.50 | $1.35 |
| 52 Week High | $208.53 | $3.55 |
| Indicator | SENEB | CMMB |
|---|---|---|
| Relative Strength Index (RSI) | 55.63 | 60.47 |
| Support Level | $187.99 | $1.47 |
| Resistance Level | $196.63 | $2.92 |
| Average True Range (ATR) | 0.43 | 0.20 |
| MACD | -0.65 | -0.03 |
| Stochastic Oscillator | 50.50 | 52.88 |
Seneca Foods Corp is a provider of packaged fruits and vegetables. The facilities are comprised of plants for packaging, can manufacturing, seed production, a farming operation and a logistical support network. It manages its business almost entirely on the basis of two reportable food packaging segments: Vegetable and Fruit/Snack. Majority of revenue comes from Vegetable segment. The Other category comprises non-food operations including revenue derived from the sale of cans, ends, seed, and outside revenue from the company's aircraft operations, and certain corporate items. Its principal product offerings include canned, frozen and jarred fruits and vegetables, as well as packaged snack chips. Its brands are Aunt Nellie's, Cherry man, GREEN VALLEY, Libby's, READ, and SENECA APPLE CHIPS.
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.